{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:19:54Z","timestamp":1790266794113,"version":"4.1.0"},"reference-count":23,"publisher":"The Endocrine Society","issue":"7","license":[{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"vor","delay-in-days":3,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,17]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Context<\/jats:title>\n                    <jats:p>Oncocytic cells can occur in benign and malignant thyroid nodules, posing a diagnostic challenge. This has reduced the diagnostic performance of molecular testing for indeterminate oncocytic thyroid nodules.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate the performance of Afirma genomic sequencing classifier (GSC) in thyroid nodules with Bethesda III or IV cytology and oncocytic predominance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design, setting, patients, and intervention<\/jats:title>\n                    <jats:p>A multicenter retrospective study was conducted in adults with Bethesda III and IV thyroid nodules showing oncocytic predominance who underwent a fine-needle aspiration biopsy and Afirma GSC testing between July 2017 and December 2023. Variables included presence of Hashimoto's thyroiditis and Thyroid Imaging Reporting and Data System (TIRADS) classification.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main outcome measures<\/jats:title>\n                    <jats:p>Outcomes included benign call rate (BCR), sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of Afirma GSC testing.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 359 nodules (57% Bethesda III, 43% Bethesda IV) tested with Afirma GSC, the mean nodule size was 2.0 cm. BCR was 81% and 74% for Bethesda III and IV nodules, respectively. GSC sensitivity, specificity, PPV, and NPV were 89%, 86%, 24%, and 99% for Bethesda III nodules and 94%, 87%, 50%, and 99% for Bethesda IV nodules, respectively. A concurrent diagnosis of Hashimoto's thyroiditis significantly reduced the specificity and PPV in Bethesda III nodules. TIRADS classification did not affect the BCR or PPV in Bethesda III or IV nodules.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Afirma GSC has a high BCR and improved performance over earlier generation molecular tests in oncocytic thyroid nodules, particularly for Bethesda IV. However, the PPV in Bethesda III nodules remains low, especially in the presence of Hashimoto's thyroiditis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1210\/clinem\/dgag044","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T12:50:33Z","timestamp":1770295833000},"page":"e1832-e1838","source":"Crossref","is-referenced-by-count":3,"title":["Utility of genomic sequencing classifier in managing cytologically indeterminate oncocytic thyroid nodules"],"prefix":"10.1210","volume":"111","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0566-6771","authenticated-orcid":false,"given":"Sara","family":"Ahmadi","sequence":"first","affiliation":[{"name":"Department of Medicine, Division of Endocrinology, Brigham and Women's Hospital, Harvard Medical School , Boston, MA 02115, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anupam","family":"Kotwal","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Diabetes, Endocrinology, and Metabolism, University of Nebraska Medical Center , Omaha, NE 68198, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6362-3772","authenticated-orcid":false,"given":"Athanasios","family":"Bikas","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Endocrinology, Brigham and Women's Hospital, Harvard Medical School , Boston, MA 02115, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin F","family":"Altshuler","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Endocrinology, Brigham and Women's Hospital, Harvard Medical School , Boston, MA 02115, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7843-5923","authenticated-orcid":false,"given":"Anery","family":"Patel","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Diabetes, Endocrinology, and Metabolism, University of Nebraska Medical Center , Omaha, NE 68198, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunjan","family":"Arora","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Diabetes, Endocrinology, and Metabolism, University of Nebraska Medical Center , Omaha, NE 68198, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7803-1240","authenticated-orcid":false,"given":"Elena G","family":"Hughes","sequence":"additional","affiliation":[{"name":"Section of Endocrine Surgery, UCLA David Geffen School of Medicine , Los Angeles, CA 90095 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jetesh","family":"Sahadeo","sequence":"additional","affiliation":[{"name":"Section of Endocrine Surgery, UCLA David Geffen School of Medicine , Los Angeles, CA 90095 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7907-4245","authenticated-orcid":false,"given":"Michael W","family":"Yeh","sequence":"additional","affiliation":[{"name":"Section of Endocrine Surgery, UCLA David Geffen School of Medicine , Los Angeles, CA 90095 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8436-392X","authenticated-orcid":false,"given":"Masha J","family":"Livhits","sequence":"additional","affiliation":[{"name":"Section of Endocrine Surgery, UCLA David Geffen School of Medicine , Los Angeles, CA 90095 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2026,2,6]]},"reference":[{"issue":"11","key":"2026061619565704700_dgag044-B1","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1089\/thy.2017.0500","article-title":"The 2017 Bethesda system for reporting thyroid cytopathology","volume":"27","author":"Cibas","year":"2017","journal-title":"Thyroid"},{"issue":"7","key":"2026061619565704700_dgag044-B2","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1089\/thy.2015.0049","article-title":"Performance of the afirma gene expression classifier in H\u00fcrthle cell thyroid nodules differs from other indeterminate thyroid nodules","volume":"25","author":"Brauner","year":"2015","journal-title":"Thyroid"},{"issue":"S2","key":"2026061619565704700_dgag044-B3","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12918-019-0693-z","article-title":"Identification of H\u00fcrthle cell cancers: solving a clinical challenge with genomic sequencing and a trio of machine learning algorithms","volume":"13","author":"Hao","year":"2019","journal-title":"BMC Syst Biol"},{"issue":"5","key":"2026061619565704700_dgag044-B4","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/cncy.22375","article-title":"H\u00fcrthle cell lesions of the thyroid: progress made and challenges remaining","volume":"129","author":"Wong","year":"2021","journal-title":"Cancer Cytopathol"},{"issue":"3","key":"2026061619565704700_dgag044-B5","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s12020-021-02932-6","article-title":"Malignancy risk in indeterminate thyroid nodules with H\u00fcrthle cells: role of autoimmune thyroiditis","volume":"75","author":"Perticone","year":"2022","journal-title":"Endocrine"},{"issue":"11","key":"2026061619565704700_dgag044-B6","doi-asserted-by":"crossref","first-page":"4069","DOI":"10.1210\/jc.2013-3584","article-title":"An independent study of a gene expression classifier (Afirma) in the evaluation of cytologically indeterminate thyroid nodules","volume":"99","author":"McIver","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2026061619565704700_dgag044-B7","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1002\/dc.24290","article-title":"Hurthle cell predominance impacts results of Afirma gene expression classifier and ThyroSeq molecular panel performance in indeterminate thyroid nodules","volume":"47","author":"Parajuli","year":"2019","journal-title":"Diagn Cytopathol"},{"issue":"9","key":"2026061619565704700_dgag044-B8","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1001\/jamasurg.2018.1153","article-title":"Performance of a genomic sequencing classifier for the preoperative diagnosis of cytologically indeterminate thyroid nodules","volume":"153","author":"Patel","year":"2018","journal-title":"JAMA Surg"},{"issue":"3","key":"2026061619565704700_dgag044-B9","doi-asserted-by":"crossref","first-page":"e428","DOI":"10.1210\/clinem\/dgz099","article-title":"Real-world comparison of Afirma GEC and GSC for the assessment of cytologically indeterminate thyroid nodules","volume":"105","author":"San Martin","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2026061619565704700_dgag044-B10","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1089\/thy.2018.0733","article-title":"Afirma gene sequencing classifier compared with gene expression classifier in indeterminate thyroid nodules","volume":"29","author":"Endo","year":"2019","journal-title":"Thyroid"},{"issue":"12","key":"2026061619565704700_dgag044-B11","doi-asserted-by":"crossref","first-page":"e2231","DOI":"10.1210\/clinem\/dgae112","article-title":"Outcomes of cytologically indeterminate thyroid nodules managed with genomic sequencing classifier","volume":"109","author":"Ahmadi","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"2026061619565704700_dgag044-B12","author":"WHO Classification of Tumours Editorial Board"},{"issue":"9","key":"2026061619565704700_dgag044-B13","first-page":"1039","article-title":"The 2023 Bethesda system for reporting thyroid cytopathology","volume":"33","author":"Ali","year":"2023","journal-title":"Thyroid\u00ae"},{"issue":"1","key":"2026061619565704700_dgag044-B14","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s12022-022-09707-3","article-title":"Overview of the 2022 WHO classification of thyroid neoplasms","volume":"33","author":"Baloch","year":"2022","journal-title":"Endocr Pathol"},{"key":"2026061619565704700_dgag044-B15","doi-asserted-by":"crossref","unstructured":"Ahmadi S, Kotwal A, Bikas A, et al \u00a0Data from: utility of genomic sequencing classifier in managing cytologically indeterminate oncocytic thyroid nodules. Figshare Digital Repository. Deposited 24 October 2025. 10.6084\/m9.figshare.30442949.","DOI":"10.1210\/clinem\/dgag044"},{"issue":"5","key":"2026061619565704700_dgag044-B16","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1089\/thy.2018.0726","article-title":"Independent comparison of the afirma genomic sequencing classifier and gene expression classifier for cytologically indeterminate thyroid nodules","volume":"29","author":"Angell","year":"2019","journal-title":"Thyroid"},{"issue":"1","key":"2026061619565704700_dgag044-B17","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.surg.2023.05.046","article-title":"Diagnostic performance of molecular testing in indeterminate (Bethesda III and IV) thyroid nodules with H\u00fcrthle cell cytology","volume":"175","author":"Raghunathan","year":"2024","journal-title":"Surgery"},{"issue":"7","key":"2026061619565704700_dgag044-B18","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1002\/jso.25875","article-title":"Differentiated thyroid cancer and Hashimoto thyroiditis: utility of the Afirma gene expression classifier","volume":"121","author":"Papoian","year":"2020","journal-title":"J Surg Oncol"},{"issue":"9","key":"2026061619565704700_dgag044-B19","doi-asserted-by":"crossref","first-page":"908","DOI":"10.4158\/EP-2018-0559","article-title":"Using the Ata and Acr Ti-Rads sonographic classifications as adjunctive predictors of malignancy for indeterminate thyroid nodules","volume":"25","author":"Ahmadi","year":"2019","journal-title":"Endocr Pract"},{"issue":"1","key":"2026061619565704700_dgag044-B20","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/lary.29778","article-title":"Ultrasonography and fine-needle aspiration in indeterminate thyroid nodules: a systematic review of diagnostic test accuracy","volume":"132","author":"Staibano","year":"2022","journal-title":"Laryngoscope"},{"issue":"11","key":"2026061619565704700_dgag044-B21","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1089\/thy.2021.0119","article-title":"Do ultrasound patterns and clinical parameters inform the probability of thyroid cancer predicted by molecular testing in nodules with indeterminate cytology?","volume":"31","author":"Figge","year":"2021","journal-title":"Thyroid"},{"issue":"3","key":"2026061619565704700_dgag044-B22","doi-asserted-by":"crossref","first-page":"bvae010","DOI":"10.1210\/jendso\/bvae010","article-title":"Ultrasound features and performance of afirma gene sequencing classifier in cytologically indeterminate thyroid nodules","volume":"8","author":"Azaryan","year":"2024","journal-title":"J Endocr Soc"},{"issue":"2","key":"2026061619565704700_dgag044-B23","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/s12020-019-02000-0","article-title":"Ultrasound characterization for thyroid nodules with indeterminate cytology: inter-observer agreement and impact of combining pattern-based and scoring-based classifications in risk stratification","volume":"66","author":"Lam","year":"2019","journal-title":"Endocrine"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgag044\/66804559\/dgag044.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/111\/7\/e1832\/66804559\/dgag044.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/111\/7\/e1832\/66804559\/dgag044.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T23:57:17Z","timestamp":1781654237000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/111\/7\/e1832\/8467186"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,6]]},"references-count":23,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,2,6]]},"published-print":{"date-parts":[[2026,6,17]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgag044","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,7]]},"published":{"date-parts":[[2026,2,6]]}}}